BioSpace News Archive

Identifai-Genetics , developer of unique AI-based solutions for non-invasive fetal DNA sequencing, announced today that it has launched its first US clinical trial, in collaboration with Columbia University and the Columbia University Irving Medical Center in New York.

Bond Biosciences has a clear path for the submission of an IND application to the FDA in the fourth quarter of 2024.

DNAnexus, Inc. today announced a partnership to simplify and accelerate variant interpretation and clinical reporting.

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract with a maximum value up to $235.8 million to supply BioThrax ® (Anthrax Vaccine Adsorbed) for use by all branches of the U.S. military as Pre-Exposure Prophylaxis (PrEP) for anthrax disease.

UroGen Pharma Ltd. today announced that Liz Barrett, President and CEO, will participate in a fireside chat at the upcoming B. Riley Virtual Healthcare Conference on January 18th.

Science Applications International Corp. has been awarded a $156 million contract to provide system support to the U.S. Army Reserve Command through their United States Army Reserve Command Information Technology Support Services contract.

Checkpoint Therapeutics, Inc. today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference, taking place on Thursday, January 18, 2024, at 4:00 p.m. EST.

Allurion Program led to resolution of type 2 diabetes, hypertension, and obstructive sleep apnea in just 4 months in over half of the patients treated.

Elicio Therapeutics, Inc. today announced that the first patient has been dosed at Northwell Health Cancer Institute and the Feinstein Institutes for Medical Research, New York, as part of the randomized Phase 2 (AMPLIFY-7P) study of ELI-002 7P as an adjuvant monotherapy in KRAS mutated pancreatic ductal adenocarcinoma (“PDAC”).

The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Intrafusion by Mckesson, Neurological Sciences of Orlando (NSO) has earned the National Infusion Center Association (NICA) Accreditation of Excellence for Ambulatory Infusion Centers.